Genomic landscape of TP53 -mutated myeloid malignancies.
Haley J AbelKarolyn A OetjenChristopher A MillerSai M RamakrishnanRyan B DayNichole M HeltonCatrina C FronickRobert S FultonSharon E HeathStefan P TarnawskySridhar Nonavinkere SrivatsanEric J DuncavageMolly C SchroederJacqueline E PaytonDavid H SpencerMatthew J WalterPeter WesterveltJohn F DiPersioTimothy J LeyDaniel C LinkPublished in: medRxiv : the preprint server for health sciences (2023)
-mutated AML/MDS is associated with altered telomere content compared with other AMLs.